Funding for practice-oriented clinical research

Lancet

Volumn 368, Issue 9532, 2006, Pages 262-266

  Rothwell, Peter M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTHROSCOPIC SURGERY; ARTICLE; BRAIN ARTERY ANEURYSM; CATARACT EXTRACTION; CLINICAL RESEARCH; COCHRANE LIBRARY; COST EFFECTIVENESS ANALYSIS; ENDOSCOPIC SURGERY; FINANCIAL MANAGEMENT; FUNDING; HEALTH CARE COST; HEALTH CARE DELIVERY; MEDICAL DECISION MAKING; MINIMALLY INVASIVE SURGERY; PREDICTION; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 33745997739     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)69010-7     Document Type: Note

References (20)

1. Gardner J. Excellence, can we be equal and excellent too? (1995), WW Norton & Company, New York
2. Horton R. Health research in the UK: the price of success. Lancet 368 (2006) 93-97
3. UK Clinical Research Collaboration. UK health research analysis: the first national analysis of health research in the UK (May 24, 2006). http://www.ukcrc.org/activities/coordinatingresearchfunding/ukhealthresearchanalysis.aspx (accessed June 30, 2006)
4. Chalmers I., Rounding C., and Lock K. descriptive survey of non-commercial randomised controlled trials in the United Kingdom, 1980-2002. BMJ 327 (2003) 1017-1019
5. Rothwell P. Medical academia is failing patients and clinicians: the neglect of basic observational clinical research. BMJ 332 (2006) 863-864
6. Rees J. The fundamentals of clinical discovery. Perspect Biol Med 47 (2004) 597-607
7. Johnston S., Rootenberg J., Katrak S., Smith W., and Elkins J. Effect of a US National Institutes of Health programme of clinical trials on public health and costs. Lancet 367 (2006) 1319-1327
8. Academy of Medical Sciences. Strengthening clinical research (October, 2003). http://www.acmedsci.ac.uk/images/publication/pscr.pdf (accessed June 30, 2006)
9. Cochrane A. Effectiveness and efficiency: random reflections on health services (1972), Nuffield Provincial Hospitals Trust, London
10. National Collaboratng Centre for Chronic Conditions. Parkinson's disease: national clinical guideline for diagnosis and management in primary and secondary care (June 28, 2006). http://www.nice.org.uk/page.aspx?o=cg035fullguideline (accessed July 10, 2006)
11. Bath P., and Gray L. Association between hormone replacement therapy and subsequent stroke: a meta-analysis. BMJ 330 (2005) 342-345
12. Rees J. Complex disease and the new clinical sciences. Science 296 (2002) 698-701
13. Pollack A. Despite billions of discoveries, pipeline of drugs is far from full. New York Times (April 19, 2002) C1
14. Nature Genetics. Freely associating. Nat Genet 22 (1999) 1-2
15. Worrall B., and Mychaleckjy J. PDE4D and stroke: a real advance or a case of the emperor's new clothes?. Stroke 37 (2006) 1955-1957
16. van der Worp H., de Haan P., Morrema E., and Kalkman C. Methodological quality of animal studies on neuroprotection in focal cerebral ischaemia. J Neurol 252 (2005) 1108-1114
17. Horn J., de Haan R., Vermeulen M., Luiten P., and Limburg M. Nimodipine in animal model experiments of focal cerebral ischemia: a systematic review. Stroke 32 (2001) 2433-2438
18. Macleod M., O'Collins T., Howells D., and Donnan G. Pooling of animal experimental data reveals influence of study design and publication bias. Stroke 35 (2004) 1203-1208
19. Macleod M., Sena E., Sandercock P., and for the CAMARADES collaboration. Sources of bias in animal models of stroke. Cerebrovasc Dis 21 suppl 4 (2006) 42
20. O'Collins V., Macleod M., Donnan G., Horky L., van der Worp B., and Howells D. 1,026 experimental treatments in acute stroke. Ann Neurol 59 (2006) 467-477